SITE MAP
Community engagement
We won’t stop until we end HIV.
- We improve our access to medicines
- Policy Papers
- Fast-Track Cities: A Network to End the Global HIV Epidemic
- Fast-Track Cities: Improving Pathways to HIV Care in Lisbon
- Our stories
- Our people are the heartbeat of our mission
- HIV Community
- We won’t stop innovating
- We are committed to advancing the global hiv response
- HIV cure: ending the HIV epidemic | ViiV Healthcare
Media centre, HIV conferences and events
Living with HIV: Supporting your Journey
- Let’s talk about HIV care together
- Living with HIV
- Starting your HIV Journey
- Living with HIV: Meet Our Authors
- Living a healthy life with HIV
- Talking to your doctor about HIV
- HIV and Tuberculosis (TB) | ViiV Healthcare
- Living with an HIV-positive person | ViiV Healthcare
- Life expectancy of someone living with HIV | ViiV Healthcare
- The power of undetectable = untransmittable (U=U) for HIV
- HIV in Women | Statistics, Facts & more | ViiV Healthcare
- Your HIV questions answered | ViiV Healthcare
- HIV Prevention: Some things you should know
- HIV testing and diagnosis insights | ViiV Healthcare
NP-GBL-HVX-COCO-220023 November 2021.
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.
If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.
